MicroRNA-195a-3p inhibits angiogenesis by targeting Mmp2 in murine mesenchymal stem cells
Related Experiment Video
Updated: Mar 24, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Fan Gao1, Meng Sun2, Yumei Gong3
1Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Abstract:
MicroRNAs (miRNAs) modulate complex physiological and pathological processes, including the regulation of angiogenesis. Our previous study reported that bone marrow-derived mesenchymal stem cells (MSCs) are recruited into choroidal neovascularization lesions. miRNA-195 is highly expressed in MSCs, but its function remains unknown. In the present study, miR-195a-3p abundance was significantly decreased in hypoxia-treated murine MSCs; on the other hand, its overexpression reduced MSC proliferation and migration while increasing the activation of anti-angiogenic factor pigment epithelium-derived factor (PEDF). We further discovered that matrix metalloproteinase 2 (Mmp2) transcript is a target of miR-195a-3p, and that silencing Mmp2 phenocopied the reduced proliferation and migration of MSCs. The therapeutic potential of miR-195a-3p as an angiogenesis inhibitor was also demonstrated in a laser-induced choroidal neovascularization mouse model. These findings collectively indicate that miR-195a-3p is a negative modulator of angiogenesis, and could be used as an angiogenesis inhibitor. Mol. Reprod. Dev. 83: 413-423, 2016. © 2016 Wiley Periodicals, Inc.
Insights
MicroRNA-195a-3p inhibits angiogenesis by reducing mesenchymal stem cell proliferation and migration. This microRNA, decreased in hypoxia, shows therapeutic potential as an angiogenesis inhibitor for conditions like choroidal neovascularization.
Area of Science:
- Molecular Biology
- Stem Cell Biology
- Ophthalmology
Background:
- MicroRNAs (miRNAs) regulate physiological and pathological processes, including angiogenesis.
- Mesenchymal stem cells (MSCs) are recruited to neovascularization lesions.
- The role of miRNA-195 in MSCs and angiogenesis is unknown.
Purpose of the Study:
- To investigate the function of miR-195a-3p in mesenchymal stem cells (MSCs).
- To determine the role of miR-195a-3p in regulating angiogenesis.
- To evaluate the therapeutic potential of miR-195a-3p as an angiogenesis inhibitor.
Main Methods:
- Assessed miR-195a-3p abundance in hypoxia-treated MSCs.
- Overexpressed miR-195a-3p in MSCs to study effects on proliferation, migration, and anti-angiogenic factors.
- Identified matrix metalloproteinase 2 (Mmp2) as a miR-195a-3p target.
- Silenced Mmp2 to observe effects on MSCs.
- Tested therapeutic potential in a laser-induced choroidal neovascularization mouse model.
Main Results:
- miR-195a-3p abundance decreased in hypoxia-treated MSCs.
- Overexpression of miR-195a-3p reduced MSC proliferation and migration.
- miR-195a-3p overexpression increased pigment epithelium-derived factor (PEDF) activation.
- Mmp2 was confirmed as a target of miR-195a-3p.
- Silencing Mmp2 mimicked the reduced proliferation and migration observed with miR-195a-3p overexpression.
- miR-195a-3p demonstrated therapeutic potential in a mouse model of choroidal neovascularization.
Conclusions:
- miR-195a-3p acts as a negative modulator of angiogenesis.
- miR-195a-3p inhibits MSC proliferation and migration, partly through targeting Mmp2.
- miR-195a-3p holds potential as a therapeutic agent for inhibiting angiogenesis in diseases like choroidal neovascularization.
Related Concept Videos
MicroRNAs
MicroRNAs
Mesenchymal Stem Cells
Regulation of Angiogenesis and Blood Supply

